###begin article-title 0
###xml 106 107 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN1">*</xref>
Kinome Sirna Screen Identifies SMG-1 as a Negative Regulator of Hypoxia-inducible Factor-1alpha in Hypoxia*
###end article-title 0
###begin p 1
Hypoxia-inducible factor-1 (HIF-1) plays a central role in tumor progression by regulating genes involved in proliferation, glycolysis, angiogenesis, and metastasis. To improve our understanding of HIF-1 regulation by kinome, we screened a kinase-specific small interference RNA library using a hypoxia-response element (HRE) luciferase reporter assay under hypoxic conditions. This screen determined that depletion of cellular SMG-1 kinase most significantly modified cellular HIF-1 activity in hypoxia. SMG-1 is the newest and least studied member of the phosphoinositide 3-kinase-related kinase family, which consists of ATM, ATR, DNA-PKcs, mTOR, and SMG-1. We individually depleted members of the phosphoinositide 3-kinase-related kinase family, and only SMG-1 deficiency significantly augmented HIF-1 activity in hypoxia. We subsequently discovered that SMG-1 kinase activity was activated by hypoxia, and depletion of SMG-1 up-regulated MAPK activity under low oxygen. Suppressing cellular MAPK by silencing ERK1/2 or by treatment with U0126, a MAPK inhibitor, partially blocked the escalation of HIF-1 activity resulting from SMG-1 deficiency in hypoxic cells. Increased expression of SMG-1 but not kinase-dead SMG-1 effectively inhibited the activity of HIF-1alpha. In addition, cellular SMG-1 deficiency increased secretion of the HIF-1alpha-regulated angiogenic factor, vascular epidermal growth factor, and survival factor, carbonic anhydrase IX (CA9), as well as promoted the hypoxic cell motility. Taken together, we discovered that SMG-1 negatively regulated HIF-1alpha activity in hypoxia, in part through blocking MAPK activation.
###end p 1
###begin p 2
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 360 367 <span type="species:ncbi:9606">patient</span>
Solid tumors contain poorly vascularized areas that are hypoxic. Hypoxic tumor cells are resistant to apoptosis, prone to migrate to less hypoxic regions of the body (metastasis), and produce pro-angiogenic factors to stimulate neovascularization leading to tumor oxygenation and tumor growth (1, 2). In fact, hypoxic tumors are typically associated with poor patient prognosis due to the aggressive and pro-angiogenic nature of hypoxic tumor cells, as well as their resistance to radiotherapy and chemotherapy (3, 4).
###end p 2
###begin p 3
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN2"><sup>2</sup></xref>
###xml 398 399 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 472 473 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 747 748 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Hypoxia-induced cancer cell responses are regulated at multiple levels, including gene transcription, protein translation, post-translational modification, and subcellular translocation (5). Hypoxia-inducible factor-1 (HIF-1),2 a heterodimer consisting of a HIF-1alpha and a HIF-1beta subunit, is the master regulator of these cellular responses to low oxygen. HIF-1alpha activity is regulated by O2-dependent degradation and by the rate of transcription and translation (6). Moreover, oncogenic ERK-dependent phosphorylation of HIF-1alpha and its coactivator p300 promotes the transcriptional activity of HIF-1alpha possibly through enhancing the accessibility of RNA polymerase II to the promoters containing hypoxia-responsive elements (HREs) (1).
###end p 3
###begin p 4
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 608 609 604 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 611 612 607 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
HIF-1 binds to HREs in the promoters or enhancers of target genes and activates the expression of at least 150 genes encoding proteins that regulate cell metabolism, survival, motility, basement membrane integrity, angiogenesis, hematopoiesis, and other functions (4). In particular, hypoxia-induced HIF-1 activation up-regulates the expression of a metastatic gene (lysyl oxidase), critical angiogenic factors (VEGF-A and Ang-2), and survival factors (carbonic anhydrase IX and XII) (1). Among these molecules, HIF-1alpha, VEGF, and carbonic anhydrase IX (CA9) proteins are clinical biomarkers for hypoxia (5, 7).
###end p 4
###begin p 5
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 310 310 310 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9"/>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 589 589 589 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12"/>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 959 961 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 985 987 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1060 1062 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
The phosphoinositide 3-kinase-related kinase (PIKK) family of high molecular mass signaling proteins comprises ATM, ATR, DNA-PKcs, mTOR, and SMG-1. PIKKs are serine-threonine kinases and mediate cellular reaction to a variety of stresses, including genome and RNA surveillance and accessibility of nutrients (8-10). Among them, SMG-1 is the newest and least studied member of the PIKKs, and was first recognized for its role in regulating nonsense-mediated mRNA decay, a cellular surveillance mechanism that degrades mRNA transcripts containing premature translation termination codons (11-13). So far, SMG-1 is known for responding to different cellular stresses. For example, like the genotoxic stress-responsive kinases, ATM, ATR, and DNA-PKcs that SMG-1 closely resembles, SMG-1 is activated by DNA damage and phosphorylates p53 during genotoxic stress (14). Moreover, SMG-1 is involved in cell survival during tumor necrosis factor-alpha-induced stress (15), lifespan regulation (16), as well as in cell cycle checkpoint signaling under oxidative stress (17).
###end p 5
###begin p 6
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 71 71 71 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19"/>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 134 136 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 136 136 132 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22"/>
###xml 137 139 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 234 235 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
It has been demonstrated that hypoxic stress inhibits mTOR activity (18-20), which may lead to suppression of HIF-1alpha translation (21-23). ATR and ATM were also indicated in the repair of hypoxia/re-oxygenation-induced DNA damage (5). However, the role of SMG-1 in regulating cellular response to hypoxia is unclear. In this study, we demonstrate that SMG-1 was activated by hypoxia in cancer cells and consequently suppressed HIF-1alpha activity in part via inhibition of the MAPK pathway, thereby reducing the hypoxia-induced secretion of angiogenic factor, VEGF, and survival factor, CA9, as well as restricting the migration of hypoxic cancer cells.
###end p 6
###begin title 7
EXPERIMENTAL PROCEDURES
###end title 7
###begin title 8

###end title 8
###begin title 9

###end title 9
###begin title 10
Cell Culture
###end title 10
###begin p 11
###xml 240 241 240 241 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 191 197 <span type="species:ncbi:9913">bovine</span>
The human cell lines HeLa, HEK293, and SKOV-3 were obtained from American Type Culture Collection (Manassas, VA). All cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum, 1% penicillin/streptomycin, and 1% l-glutamine (Invitrogen).
###end p 11
###begin title 12
Cell Transfections
###end title 12
###begin p 13
###xml 351 352 351 352 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 524 526 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 556 563 554 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 603 611 601 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 908 915 906 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
The siRNA library contained Smart-pool libraries (Dharmacon, Lafayette, CO) of 4 siRNA duplexes per gene targeting 779 protein kinases, lipid kinases, and regulatory subunits. For siRNA transfection, HeLa or SKOV-3 cells were plated in 24-well plates in complete medium. After 24 h, cells were transfected with siRNA at the final concentration of 25 nm using the Dharmafect I (Dharmacon). After a further 24 h, cells were transfected with 0.3 mug of HRE luciferase reporter plasmid (a kind gift from Dr. Navdeep S. Chandel (24)) and 0.03 mug of control TK-Renilla reference plasmid DNA using GenJet DNA in vitro transfection reagent (SignaGen Laboratories, Gaithersburg, MD) following the manufacturer's instructions. 48 h after siRNA transfection, Luciferase values were determined using a dual-luciferase reporter assay kit (Promega, Madison, WI). Values from Firefly luciferase were normalized to control Renilla luciferase, which is under the control of the thymidine kinase promoter in the pRLTK vector.
###end p 13
###begin title 14
Antibodies and Immunoblotting
###end title 14
###begin p 15
###xml 419 421 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 470 472 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 676 677 672 673 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 709 710 705 706 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 744 745 740 741 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 823 825 818 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 864 865 859 860 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 480 486 <span type="species:ncbi:9986">rabbit</span>
###xml 496 501 <span type="species:ncbi:10090">mouse</span>
Anti-HA antibody was purchased from the core facility of The Scripps Research Institute (San Diego, CA). Anti-phospho-p70S6K (Thr-389) antibody was from Upstate (Lake Placid, NY). Anti-ATM, anti-ATR, anti-mTOR, anti-DNA-PK, anti-HIF-1alpha, anti-ERK1/2, anti-phospho-AKT (Ser-473), and anti-phospho-ERK1/2 (Thr-202/Tyr-204) antibodies were from Cell Signaling (Boston, MA). Anti-BMK1 antibody was previously described (25). Anti-SMG-1 antibody was previously described (15). Anti-rabbit and anti-mouse secondary antibodies were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). For immunoblotting, cells were lysed in radioimmune precipitation assay buffer (9.1 mm dibasic sodium phosphate, 1.7 mm monobasic sodium phosphate, 150 mm NaCl, pH 7.4, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 100 mug ml-1 phenylmethylsulfonyl fluoride, and 1 mm sodium orthovanadate). Samples were resolved by 6 or 8% SDS-PAGE and examined by Western blotting.
###end p 15
###begin title 16
Immune Complex Kinase Assays
###end title 16
###begin p 17
###xml 232 240 231 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 420 421 419 420 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 446 447 445 446 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 470 471 469 470 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 730 731 728 729 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 752 753 750 751 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 764 765 762 763 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 913 914 901 902 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 935 936 923 924 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 941 942 929 930 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1020 1021 1006 1007 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
HEK293 cells were seeded onto a 100-mm dish and transfected with 30 mug of HA-tagged wild-type SMG-1 (HA-SMG-1-WT) (a kind gift from Dr. Robert T. Abraham and Dr. Lynne E. Maquat) or kinase-dead SMG-1 (HA-SMG-1-KD) using GenJet DNA in vitro transfection reagent (SignaGen Laboratories). After 48 h, cells were subjected to hypoxia (1% oxygen) for the indicated time, and cell extracts were prepared in lysis buffer (50 mm Tris-HCl (pH 7.4), 150 mm NaCl, 1% Tween 20, 1 mm dithiothreitol) with protease and phosphatase inhibitors. HA-tagged recombinant proteins were immunoprecipitated from cell extracts with 6 mug of anti-HA antibody. The immunoprecipitates were washed four times in lysis buffer, and once in kinase buffer (10 mm HEPES (pH 7.4), 50 mm NaCl, 50 mm beta-glycerophosphate). Kinase reactions were performed for 30 min at 30 degreesC after adding 40 mul of kinase buffer containing 10% glycerol, 1 mm dithiothreitol, 10 mm MnCl2, protease, and phosphatase inhibitors, 1 mug of recombinant PHAS-1, and 10 mum ATP to each sample. The kinase activity was measured using the Kinase-Glo Luminescent Kinase Assay Platform (Promega) by quantitating the amount of ATP remaining in solution following the kinase reaction.
###end p 17
###begin title 18
Immunoassays
###end title 18
###begin p 19
###xml 431 436 <span type="species:ncbi:9606">human</span>
###xml 787 798 <span type="species:ncbi:3704">horseradish</span>
VEGF and CA9 concentrations in cell culture supernatants were measured using immunoassay kits from Pierce (Rockford, IL) and from R&D Systems (Minneapolis, MN), respectively. In brief, HeLa cells were transfected with SMG-1 siRNA. After 24 h, the cells were starved and incubated under hypoxic conditions (1% oxygen) at 37 degreesC overnight. Cell culture medium (50 mul) was added to each well of a microplate precoated with anti-human VEGF or CA9 polyclonal antibody and incubated for 2 h at room temperature. Each well was washed with wash buffer. For VEGF, 100 mul of biotinylated antibody was added to each well, and the mixture was incubated for 1 h. For CA9, 200 mul of carbonic anhydrase IX conjugate was added, and the mixture was incubated for 2 h. After washing, streptavidin-horseradish peroxidase was added to each well, and the mixture was incubated for 30 min. Following washes, a substrate solution was added to each well. After incubation for 30 min at room temperature, the enzyme reaction was stopped, and the intensity was measured at 450 nm. The data were normalized using the cell number determined by methylthiazolyldiphenyltetrazolium bromide (MTT, Sigma).
###end p 19
###begin title 20
Cell Motility Assays
###end title 20
###begin p 21
###xml 177 178 177 178 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 183 184 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 191 192 191 192 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 197 198 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 203 204 203 204 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 209 210 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 358 359 356 357 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 217 223 <span type="species:ncbi:9913">bovine</span>
###xml 807 813 <span type="species:ncbi:3635">cotton</span>
SKOV-3 cells were harvested with Trypsin/EDTA, washed twice with Dulbecco's modified Eagle's medium, and resuspended in migration buffer (Dulbecco's modified Eagle's medium, 2 mm MnCl2, 1.8 mm MgCl2, 2 mm CaCl2, 0.5% bovine serum albumin) at a density of 106/ml. Lower chambers (Corning, NY) were filled with 600 mul of warm migration buffer containing 20 mum fibronectin (BD Biosciences) as the attractant, and the upper chambers were filled with 100 mul of the cell suspension. After 5-h incubation in the hypoxic chamber (1% oxygen) at 37 degreesC, cells were fixed for 30 min at room temperature in 5% glutaraldehyde prepared in phosphate-buffered saline, and stained for 30 min in 0.1% crystal violet and 2% ethanol. Non-migratory cells on the upper surface of the filter were removed by wiping with a cotton swab. The number of migratory cells was measured by counting three random fields per filter. Mean values were obtained from at least three separate experiments.
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23

###end title 23
###begin title 24

###end title 24
###begin title 25
SMG-1 Suppresses HIF-1 Activity under Hypoxic Conditions
###end title 25
###begin p 26
###xml 381 387 377 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 387 388 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 588 594 584 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 594 595 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 686 692 682 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 692 693 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 933 939 929 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 939 940 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1216 1222 1212 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1222 1223 1218 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1504 1510 1500 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1510 1511 1506 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
To explore the role of kinases in regulating HIF-1 activity under hypoxia, we depleted kinases in tumor cells using a siRNA kinase library targeting 779 kinases and then analyzed cellular HIF-1 activity under oxygen deprivation using an HRE luciferase reporter assay. In this assay, hypoxia strongly increased HRE luciferase activity and HIF-1alpha protein stabilization in cells (Fig. 1A). Among the 779 kinases screened by siRNA-mediated silencing, depletion of 18 kinases significantly increased HIF-1 activity and another 10 kinases decreased HIF-1 activity under hypoxic conditions (Fig. 1B). Among these kinases, the depletion of SMG-1 impacted HIF-1 activity most significantly (Fig. 1B). SMG-1 belongs to the PIKK family of protein kinases. We found that siRNA-mediated depletion of SMG-1, but not other members of the PIKK family, ATM, ATR, DNA-PKcs, and mTOR, markedly increased the HIF-1 activity in hypoxic cancer cells (Fig. 2A). To further confirm that the increase in hypoxia-induced HIF-1 activity in SMG-1-depleted cells was directly related to an on-target effect of the siRNA, we repeated this experiment using four different siRNA duplexes to deplete cellular SMG-1 and obtained similar results (Fig. 2B). Next, we forced expression of wild-type (WT) SMG-1 and its kinase-dead (KD) mutant separately in SMG-1-depleted cell and found that forced expression of WT, but not KD SMG-1, could reverse the increased HIF-1 activity observed in hypoxic tumor cells depleted of cellular SMG-1 (Fig. 2C). These results confirmed that SMG-1 deficiency increased HIF-1 activity in hypoxia and suggested that cellular SMG-1 activity is critical in suppressing HIF-1 activation in hypoxic cancer cells.
###end p 26
###begin p 27
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Screening the human kinome for regulators of HIF-1 activity.</bold>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 399 406 393 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 614 615 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 725 729 715 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cont</italic>
###xml 1102 1103 1086 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1206 1213 1190 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1251 1252 1235 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1260 1261 1244 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 1318 1328 1302 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Error bars</italic>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 689 694 <span type="species:ncbi:9606">human</span>
Screening the human kinome for regulators of HIF-1 activity.A, HeLa cells were transfected with HRE- and pRL-TK luciferase reporter plasmids. 24 h after transfection, cells were incubated in the hypoxic chamber (1% oxygen) at 37 degreesC overnight. Luciferase values were determined in these cells using a dual-luciferase reporter assay kit. Values for firefly luciferase were normalized by control Renilla luciferase activities. The normalized luciferase activity of control hypoxic cells was taken as 1. Induction of HIF-1 protein by hypoxia was monitored by Western blot analysis with anti-HIF-1alpha antibody. B, HeLa cells were transfected with Smart-pool siRNA library targeting the human kinome or with control siRNA (Cont) as indicated. After 24 h, cells were transfected with HRE- and pRL-TK luciferase reporter plasmids. 48 h after siRNA transfection, cells were incubated in the hypoxic chamber (1% oxygen) at 37 degreesC overnight. Luciferase values were determined as described above. The normalized luciferase activity of control hypoxic cells was taken as 1. The activity of luciferase (M) was quantified by measurement of the ratio of firefly luciferase activity as standardized to that of Renilla luciferase. The subset of genes with M > 2 or M < 0.7 were chosen for further confirmatory experiments. Error bars represent the +/-S.D. of three independent experiments.
###end p 27
###begin p 28
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Depletion of SMG-1 augmented the HIF-1 activity under hypoxic conditions.</bold>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cont</italic>
###xml 354 360 354 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 636 637 636 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DP1&#8211;4</italic>
###xml 729 731 729 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SP</italic>
###xml 746 750 746 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cont</italic>
###xml 998 1009 998 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 1012 1013 1012 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1177 1188 1177 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HA-SMG-1-WT</italic>
###xml 1212 1223 1212 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HA-SMG-1-KD</italic>
###xml 1523 1534 1523 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
Depletion of SMG-1 augmented the HIF-1 activity under hypoxic conditions.A, HeLa cells were transfected with Smart-pool siRNAs for individual members of the PIKK family or with control siRNA (Cont) as indicated. After 24 h, cells were transfected with reporter plasmids, incubated in hypoxia chamber, and analyzed for luciferase activity as described in Fig. 1. The normalized luciferase activity of control hypoxic cells was taken as 1. The protein levels of endogenous SMG-1, ATM, ATR, mTOR, and DNA-PK were detected by Western blotting using antibodies specific to each of these proteins (described under "Experimental Procedures"). B, HeLa cells were transfected with four different SMG-1 siRNA duplexes (DP1-4), Smart-pool (SP), or control (Cont) siRNAs. After 24 h, cells were transfected with reporter plasmids, incubated in the hypoxia chamber, and analyzed for luciferase activity as described above. Endogenous SGM-1 protein was detected by Western blotting using an anti-SMG-1 antibody (lower panel). C, HeLa cells were transfected with SMG-1 siRNA. After 24 h, cells were transfected with empty vector or the expression plasmids encoding HA-tagged wild-type SMG-1 (HA-SMG-1-WT) or kinase dead SMG-1 (HA-SMG-1-KD). HRE and pRL-TK luciferase reporter plasmids were also included in the transfection mixture. The luciferase activity in SMG-1-deficient cells transfected with empty vector was taken as 100%. The expression of HA-SMG-1-WT and HA-SMG-1-KD were detected by Western blotting using an anti-HA antibody (lower panel).
###end p 28
###begin title 29
SMG-1 Is Activated by Hypoxic Stress and Subsequently Suppresses HIF-1 Activity in Low Oxygen in Part through Repression of MAPK Activation
###end title 29
###begin p 30
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 371 377 371 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 682 688 682 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 688 689 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1135 1141 1135 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1141 1142 1141 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1308 1314 1308 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1314 1315 1314 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
Because SMG-1 is known to be activated under various cellular stresses (14), we investigated whether SMG-1 kinase can also be activated under hypoxic stress. We expressed WT and KD SMG-1 in tumor cells followed by hypoxia treatment and found that the kinase activity of WT SMG-1, but not KD SMG-1, was substantially up-regulated for at least 18 h in response to hypoxia (Fig. 3A). To determine whether the activated SMG-1 kinase had an effect on other cellular kinase cascades, we analyzed the ERK1/2, mTOR, AKT, and BMK1 kinase pathways and found that depletion of cellular SMG-1 altered only the intensity of ERK1/2 activation, but not the other pathways, in response to hypoxia (Fig. 3B). Moreover, kinase library screen indicated that depletion of ERK1 significantly decreased the HIF-1 activity. Thus, we suspected that SMG-1 inhibited HIF-1 activity through suppression of ERK1/2 activities under hypoxic conditions. To test this, we depleted ERK1 and/or ERK2 in SMG-1-deficient cells and found that ERK1, but not ERK2, knockdown partially reduced the SMG-1 deficiency-dependent up-regulation of HIF-1 activity in hypoxic cells (Fig. 3C). Similar results were obtained by treating SMG-1-deficient cells with the MEK1 inhibitor, U0126 (Calbiochem), to suppress ERK1/2 activity under hypoxic conditions (Fig. 3D). These results suggested that SMG-1 inhibited the HIF-1 activity through partial repression of MAPK activity in hypoxic tumor cells.
###end p 30
###begin p 31
###xml 0 141 0 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMG-1 was activated by hypoxic stress and subsequently suppressed HIF-1&#945; activity under low oxygen through inhibition of MAPK activation.</bold>
###xml 141 142 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 192 194 188 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 212 214 208 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KD</italic>
###xml 601 612 597 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 615 616 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1148 1149 1134 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1216 1220 1202 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cont</italic>
###xml 1399 1405 1385 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1591 1592 1577 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1636 1640 1622 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cont</italic>
###xml 1814 1815 1799 1800 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
SMG-1 was activated by hypoxic stress and subsequently suppressed HIF-1alpha activity under low oxygen through inhibition of MAPK activation.A, HEK293 cells were transfected with HA-SMG-1-WT (WT) or HA-SMG-1-KD (KD) expression vector. After 48 h, these cells were treated under hypoxia for the indicated time. HA-tagged SMG-1 proteins were immunoprecipitated and analyzed for their kinase activities using PHAS-1 as substrate. Kinase activity of HA-SMG-1-KD in cells without hypoxia was taken as 1. The expression of HA-SMG-1-WT and HA-SMG-1-KD were detected in a Western blot using anti-HA antibody (lower panel). B, HeLa cells were transfected with SMG-1 siRNA. After 48 h, these cells were incubated in the hypoxic chamber at 37 degreesC for indicated time. The levels of phospho-ERK1/2, ERK1/2, phospho-AKT, phospho-p70S6K, HIF-1alpha, and BMK1 in these cells were analyzed by Western blot using specific antibodies (described under "Experimental Procedures"). The relative phosphorylation of ERK1 was determined by setting the phosphorylation, measuring by densitometry, for mock-transfected cells without hypoxia treatment at a value of 1.0. C, HeLa cells were cotransfected with SMG-1 siRNA and with control (Cont), ERK1, ERK2, or ERK1/2 siRNAs. After 24 h, cells were transfected with reporter plasmids, incubated in the hypoxia chamber, and analyzed for luciferase activity as described in Fig. 1. The luciferase activity in cells cotransfected with SMG-1 and control siRNAs was taken as 1. The levels of ERK1/2 in these cells were detected by anti-ERK1/2 antibody in Western blot. D, HeLa cells were transfected with control (Cont) or SMG-1 siRNA. After 24 h, these cells were transfected with HRE- and pRL-TK luciferase reporter plasmids. 48 h after siRNA transfection, the cells were treated with 10 mum of U0126 for 1 h as indicated and incubated in the hypoxic chamber at 37 degreesC overnight. The luciferase activity in cells transfected with control SMG-1 siRNAs without U0126 treatment was taken as 1. The levels of phospho-ERK1/2 and ERK1/2 in these cells were analyzed by Western blot using anti-phospho-ERK1/2 and anti-ERK1/2 antibodies.
###end p 31
###begin title 32
The Kinase Activity of SMG-1 Is Required to Negatively Regulate HIF-1alpha Transcriptional Activity
###end title 32
###begin p 33
###xml 409 415 409 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 746 752 730 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 752 753 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
Because the kinase activity of SMG-1 is up-regulated by hypoxic stress and SMG-1 inhibits HIF-1 activity during hypoxic conditions, we suspected that the kinase activity of SMG-1 played a role in controlling HIF-1-transactivating activity in hypoxic cells. We increased expression of WT or KD SMG-1 in hypoxia cancer cells and found that WT but not KD SMG-1 could block HIF-1 activity in cells under hypoxia (Fig. 4A). Because HIF-1alpha is a master regulator for hypoxia-induced cellular responses, we next investigated whether SMG-1 had an effect on HIF-1alpha transcriptional activity. Co-expression of WT SMG-1, but not KD SMG-1, with HIF-1alpha demonstrated that SMG-1 inhibited HIF-1alpha-mediated transcription in a dose-dependent manner (Fig. 4B). These results suggested that the kinase activity of SMG-1 was critical in suppressing HIF-1alpha activity in tumor cells under hypoxia.
###end p 33
###begin p 34
###xml 0 101 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The kinase activity of SMG-1 was required to negatively regulate HIF-1&#945; transactivation activity.</bold>
###xml 101 102 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 151 153 147 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EV</italic>
###xml 169 171 165 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 190 192 186 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KD</italic>
###xml 419 421 409 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EV</italic>
###xml 542 553 532 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
###xml 556 557 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 707 709 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 756 758 738 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 774 776 756 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KD</italic>
###xml 1230 1241 1200 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower panel</italic>
The kinase activity of SMG-1 was required to negatively regulate HIF-1alpha transactivation activity.A, HeLa cells were transfected with empty vector (EV), HA-SMG-1-WT (WT), or HA-SMG-1-KD (KD) expression plasmid together with HRE- and pRL-TK luciferase reporter plasmids. After 24 h, cells were incubated in the hypoxic chamber at 37 degreesC overnight. The luciferase activity of cells transfected with empty vector (EV) was taken as 100%. The expression of HA-SMG-1-WT and HA-SMG-1-KD were detected in Western blot using anti-HA antibody (lower panel). B, HeLa cells were cotransfected with HIF-1alpha expression plasmid (pcDNA3.0-HA-HIF-1alpha P402A; P564A, a kind gift from Dr. William G. Kaelin, Jr. (39)) and with an increasing amount of HA-SMG-WT (WT) or HA-SMG-KD (KD) plasmids as indicated. HRE and pRL-TK luciferase reporter plasmids were also included in transfection mixture. 48 h later, the luciferase activities of these cells were analyzed. The luciferase activity of control cells transfected without any HIF-1alpha, HA-SMG-1-WT, or HA-SMG-1-KD plasmids was taken as 1. The expression of HIF-1alpha or HA-SMG-1-WT/HA-SMG-1-KD were detected in Western blot using anti-HIF-1alpha or anti-HA antibody, respectively (lower panel).
###end p 34
###begin title 35
SMG-1 Negatively Regulates the Secretion of VEGF and CA9 and the Migratory Potential of Hypoxic Tumor Cells
###end title 35
###begin p 36
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 502 508 502 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 510 511 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 965 971 965 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 971 972 971 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1115 1120 <span type="species:ncbi:9606">human</span>
Increased VEGF and CA9 proteins in epithelial cancers are markers of tumor hypoxia and are associated with a poor prognosis, because expression of VEGF and CA9 promotes tumor-associated angiogenesis and the survival capacity of hypoxic tumors, respectively (5, 7). Because both VEGF and CA9 expression are tightly regulated by HIF-1 activity, we suspected that removal of SMG-1, a negative regulator of HIF-1, would substantially enhance the production of VEGF and CA9 in tumor cells under hypoxia. In Fig. 5 (A and B), we demonstrated that in SMG-1-deficient cells the production of VEGF and CA9 was substantially elevated under hypoxia. As hypoxic conditions significantly enhance tumor metastasis partly by boosting the migratory potential of tumor cells, we tested whether depletion of cellular SMG-1 had any effect on hypoxic tumor cell motility. Indeed, we found that SMG-1 depletion significantly promoted the migratory potential of cancer cells in hypoxia (Fig. 5C). These results indicated that SMG-1 repressed a range of malignant responses induced by oxygen deprivation of tumor cells and suggested that human SMG-1 was a tumor suppressor, particularly for hypoxic tumors.
###end p 36
###begin p 37
###xml 0 117 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMG-1 negatively regulated the secretion of VEGF and CA-9, as well as the migratory potential of hypoxic tumor cells.</bold>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cont</italic>
###xml 572 573 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 611 615 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mock</italic>
###xml 652 656 646 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cont</italic>
###xml 674 679 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMG-1</italic>
SMG-1 negatively regulated the secretion of VEGF and CA-9, as well as the migratory potential of hypoxic tumor cells.A and B, HeLa cells were transfected with SMG-1 or control (Cont) siRNAs. After 48 h, the cells were incubated in 20% oxygen or 1% oxygen at 37 degreesC overnight. VEGF or CA9 protein in cell culture supernatants was measured using immunoassay kits from Pierce or R&D Systems, respectively, and the resultant data were normalized by cell number determined by MTT. The normalized VEGF or CA9 concentration of control cells under 20% oxygen was taken as 1. C, SKOV-3 cells were mock transfected (Mock) or transfected with control siRNA (Cont) or SMG-1 siRNA (SMG-1). 48 h post transfection, the migratory capacity of the cells in hypoxia was analyzed, and the relative rate of cell migration in these cells was normalized to mock transfected cells whose value was taken as 1.
###end p 37
###begin title 38
DISCUSSION
###end title 38
###begin p 39
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 236 238 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 806 808 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 808 808 796 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29"/>
###xml 808 808 796 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30"/>
###xml 809 811 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 329 334 <span type="species:ncbi:9606">human</span>
###xml 417 422 <span type="species:ncbi:9606">human</span>
Hypoxia occurs in the majority of tumors, promoting angiogenesis, metastasis, and resistance to therapy (26). HIF-1 is a master transcriptional activator of approximately100-200 genes that promote adaptation and survival under hypoxia (27). To identify novel kinase regulators of HIF-1, we screened a siRNA library targeting 779 human kinases and used the HRE reporter assay as readout under hypoxia. Among these 779 human kinases, we found that 18 kinases positively regulated HIF-1 activity. Especially, the depletion of ERK1 and MAPK3K1, two key kinases of the ERK MAPK pathway, significantly decreased HIF-1 activity. It has been reported that treatment of tumor cells with the MEK1/2 inhibitors PD98059 or U0216, or expression of a dominant-negative form of ERK1, blocked HIF-1 activation in hypoxia (28-31). Herein, using specific siRNA targeting of cellular ERK1 or MAPK3K1, we confirmed that the MAPK positively regulated the HIF-1 activity under hypoxia.
###end p 39
###begin p 40
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
On the other hand, we discovered that the depletion of 10 other kinases significantly increased the HIF-1 activity. Among these kinases, it has been reported that suppression of DUSP1 (32) and VRK2 (33) could result in up-regulation of HIF-1 activity in hypoxic conditions. Interestingly, of these novel candidates that negatively regulate HIF-1 activity, the depletion of SMG-1 had the strongest enhancing effect on HIF-1 activity.
###end p 40
###begin p 41
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
SMG-1, the newest member of the PIKK family, contains a large (>1000 amino acid) insert region between the kinase domain and FATC domain (9, 11, 12, 34). Moreover, SMG-1 is found in both the cytoplasmic and nuclear compartments (14, 35), unlike the related genotoxic stress-responsive kinases, ATM and ATR, which are confined to the nucleus in most cells (36). The cytoplasmic presence of SMG-1 suggests that this PIKK may play additional roles other than stress signaling restricted within the nucleus such as DNA repair. In this study, we found that SMG-1 was activated under hypoxic conditions, the depletion of cellular SMG-1 significantly enhanced HIF-1alpha activity, and increasing expression of SMG-1 markedly inhibited HIF-1alpha activity. These results implied that SMG-1 activity potently suppressed HIF-1-dependent cellular responses in hypoxic cells. However, the activity of mTOR, another member of the PIKK family, was inhibited by hypoxic stress, thereby suppressing HIF-1alpha protein translation. These observations suggest that hypoxia induces activation of SMG-1 and deactivation of mTOR pathways to contain the HIF-1alpha activity at post-translational and translational levels, correspondingly, thereby maintaining appropriate cellular responses for numerous physiological and pathological conditions under hypoxia.
###end p 41
###begin p 42
###xml 1014 1016 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1292 1300 1256 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1302 1304 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1306 1308 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1491 1492 1451 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1494 1496 1454 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
HIF-1alpha activity is regulated in two major ways. The first relies on hydroxylation-dependent degradation/inactivation. The second involves control of HIF-1alpha protein synthesis via the phosphatidylinositol 3-kinase/AKT and MAPK pathways. To investigate the mechanism of HIF-1alpha activity in SMG-1-deficient cells, we first studied the effect on the stability of HIF-1alpha of SMG-1 deficiency under hypoxia and found that SMG-1 knockdown did not affect HIF-1alpha stability, which suggests that SMG-1 does not involve in the regulation of von Hippel-Lindau ubiquitin ligase complex. HIF-1alpha activity is also regulated by AKT, mTOR, and MAPK. To determine whether the activated SMG-1 kinase had an effect on other cellular kinase cascades, we analyzed the ERK1/2, mTOR, AKT, and BMK1 kinase pathways and found that depletion of cellular SMG-1 altered only the intensity of ERK1/2 activation. ERK1/2 activity is up-regulated by oxygen deficiency and is involved in HIF-1 activation in hypoxic tumor cells (31). Our siRNA library screen result indicated that ERK1 is a positive regulator of HIF-1alpha. Furthermore, we found that SMG-1 inhibited the HIF-1alpha transactivation activity in part though suppressing MAPK ERK1 in hypoxia. ERK1/2 has been shown to phosphorylate HIF-1alpha in vitro (28, 37). MAPKs are critical for the transactivation activities of both HIF-1alpha and p300 through promoting HIF-1-p300 interaction by mediating the phosphorylation of these two molecules (1, 28). Therefore, it is very likely that the activation of SMG-1 by low oxygen restrains the hypoxia-induced malignant responses in tumor cells partially through inhibition of the MAPK pathway and the consequent HIF-1alpha activation.
###end p 42
###begin p 43
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 567 572 <span type="species:ncbi:9606">human</span>
Hypoxia promotes a range of malignant responses in tumor cells such as proliferation, survival, angiogenesis, migration, and metastasis (4). Herein, we demonstrated that SMG-1 activity is critical, in hypoxic tumor cells, in repressing HIF-1 activity and consequent secretion of the angiogenic factor, VEGF, and the survival factor, CA9, and in blocking cell motility under low oxygen conditions as well. There are reports from the COSMIC data base of The Sanger Institute (38) describing mutations of SMG-1 in its kinase, TS, and insertion regions that are found in human breast cancers. It should be interesting to further investigate whether these mutations compromise the ability of SMG-1 to suppress HIF-1 activity in hypoxia and consequently augment the malignant potential of hypoxic breast tumor cells.
###end p 43
###begin p 44
###xml 391 396 <span type="species:ncbi:9606">human</span>
###xml 629 637 <span type="species:ncbi:9606">patients</span>
Herein, we demonstrated that SMG-1 was a strong negative regulator for hypoxia-induced tumor cell responses such as the secretion of angiogenic factor, VEGF, and survival factor, CA9, as well as for hypoxic tumor cell motility. Thus, our findings have important prognostic and therapeutic implications for the treatment of hypoxic tumors. Analysis of SMG-1 expression levels or mutations in human cancer could be used as a biological marker to predict efficacy of treatment with MAPK or angiogenesis inhibitors. SMG-1 targeted drugs up-regulating SMG-1 protein, mRNA levels, and/or its activity could be used for treating cancer patients, in combination with angiogenesis inhibitors and/or other traditional cancer therapeutic approaches such as chemo- and radiotherapies.
###end p 44
###begin p 45
###xml 170 177 <span type="species:ncbi:4097">Tobacco</span>
This work was supported, in whole or in part, by National Institutes of Health Grants CA079871 and CA114059 (to J.-D. L.). This work was also supported by funds from the Tobacco-Related Disease, Research Program of the University of California (Grant 15RT-0104 to J.-D. L.).
###end p 45
###begin p 46
###xml 28 33 28 33 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">HIF-1</term>
###xml 33 59 33 59 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="47">hypoxia-inducible factor-1</p>
###xml 33 59 33 59 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="47">hypoxia-inducible factor-1</p></def>
###xml 28 59 28 59 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">HIF-1</term><def><p textid="47">hypoxia-inducible factor-1</p></def></def-item>
###xml 59 62 59 62 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">HRE</term>
###xml 62 88 62 88 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">hypoxia-responsive element</p>
###xml 62 88 62 88 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">hypoxia-responsive element</p></def>
###xml 59 88 59 88 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">HRE</term><def><p textid="48">hypoxia-responsive element</p></def></def-item>
###xml 88 93 88 93 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">siRNA</term>
###xml 93 114 93 114 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="49">small interfering RNA</p>
###xml 93 114 93 114 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="49">small interfering RNA</p></def>
###xml 88 114 88 114 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">siRNA</term><def><p textid="49">small interfering RNA</p></def></def-item>
###xml 114 118 114 118 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">PIKK</term>
###xml 118 158 118 158 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="50">phosphoinositide 3-kinase-related kinase</p>
###xml 118 158 118 158 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="50">phosphoinositide 3-kinase-related kinase</p></def>
###xml 114 158 114 158 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">PIKK</term><def><p textid="50">phosphoinositide 3-kinase-related kinase</p></def></def-item>
###xml 158 160 158 160 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">WT</term>
###xml 160 169 160 169 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">wild type</p>
###xml 160 169 160 169 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="51">wild type</p></def>
###xml 158 169 158 169 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">WT</term><def><p textid="51">wild type</p></def></def-item>
###xml 169 171 169 171 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">KD</term>
###xml 171 182 171 182 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="52">kinase-dead</p>
###xml 171 182 171 182 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="52">kinase-dead</p></def>
###xml 169 182 169 182 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">KD</term><def><p textid="52">kinase-dead</p></def></def-item>
###xml 182 185 182 185 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">CA9</term>
###xml 185 206 185 206 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="53">carbonic anhydrase IX</p>
###xml 185 206 185 206 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="53">carbonic anhydrase IX</p></def>
###xml 182 206 182 206 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">CA9</term><def><p textid="53">carbonic anhydrase IX</p></def></def-item>
###xml 206 209 206 209 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">MTT</term>
###xml 209 251 209 251 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54">methylthiazolyldiphenyltetrazolium bromide</p>
###xml 209 251 209 251 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="54">methylthiazolyldiphenyltetrazolium bromide</p></def>
###xml 206 251 206 251 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">MTT</term><def><p textid="54">methylthiazolyldiphenyltetrazolium bromide</p></def></def-item>
###xml 251 255 251 255 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">VEGF</term>
###xml 255 287 255 287 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="55">vascular epidermal growth factor</p>
###xml 255 287 255 287 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="55">vascular epidermal growth factor</p></def>
###xml 251 287 251 287 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">VEGF</term><def><p textid="55">vascular epidermal growth factor</p></def></def-item>
###xml 287 291 287 291 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G10">mTOR</term>
###xml 291 320 291 320 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="56">mammalian target of rapamycin</p>
###xml 291 320 291 320 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="56">mammalian target of rapamycin</p></def>
###xml 287 320 287 320 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G10">mTOR</term><def><p textid="56">mammalian target of rapamycin</p></def></def-item>
###xml 320 324 320 324 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G11">MAPK</term>
###xml 324 356 324 356 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="57">mitogen-activated protein kinase</p>
###xml 324 356 324 356 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="57">mitogen-activated protein kinase</p></def>
###xml 320 356 320 356 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G11">MAPK</term><def><p textid="57">mitogen-activated protein kinase</p></def></def-item>
###xml 356 358 356 358 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G12">HA</term>
###xml 358 371 358 371 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="58">hemagglutinin</p>
###xml 358 371 358 371 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="58">hemagglutinin</p></def>
###xml 356 371 356 371 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G12">HA</term><def><p textid="58">hemagglutinin</p></def></def-item>
###xml 371 374 371 374 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G13">ERK</term>
###xml 374 411 374 411 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59">extracellular signal-regulated kinase</p>
###xml 374 411 374 411 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="59">extracellular signal-regulated kinase</p></def>
###xml 371 411 371 411 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G13">ERK</term><def><p textid="59">extracellular signal-regulated kinase</p></def></def-item>
###xml 411 414 411 414 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G14">MEK</term>
###xml 414 429 414 429 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="60">MAPK/ERK kinase</p>
###xml 414 429 414 429 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="60">MAPK/ERK kinase</p></def>
###xml 411 429 411 429 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G14">MEK</term><def><p textid="60">MAPK/ERK kinase</p></def></def-item>
###xml 429 431 429 431 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G15">TS</term>
###xml 431 441 431 441 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="61">TOR SMG-1.</p>
###xml 431 441 431 441 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="61">TOR SMG-1.</p></def>
###xml 429 441 429 441 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G15">TS</term><def><p textid="61">TOR SMG-1.</p></def></def-item>
###xml 28 441 28 441 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">HIF-1</term><def><p textid="47">hypoxia-inducible factor-1</p></def></def-item><def-item><term id="G2">HRE</term><def><p textid="48">hypoxia-responsive element</p></def></def-item><def-item><term id="G3">siRNA</term><def><p textid="49">small interfering RNA</p></def></def-item><def-item><term id="G4">PIKK</term><def><p textid="50">phosphoinositide 3-kinase-related kinase</p></def></def-item><def-item><term id="G5">WT</term><def><p textid="51">wild type</p></def></def-item><def-item><term id="G6">KD</term><def><p textid="52">kinase-dead</p></def></def-item><def-item><term id="G7">CA9</term><def><p textid="53">carbonic anhydrase IX</p></def></def-item><def-item><term id="G8">MTT</term><def><p textid="54">methylthiazolyldiphenyltetrazolium bromide</p></def></def-item><def-item><term id="G9">VEGF</term><def><p textid="55">vascular epidermal growth factor</p></def></def-item><def-item><term id="G10">mTOR</term><def><p textid="56">mammalian target of rapamycin</p></def></def-item><def-item><term id="G11">MAPK</term><def><p textid="57">mitogen-activated protein kinase</p></def></def-item><def-item><term id="G12">HA</term><def><p textid="58">hemagglutinin</p></def></def-item><def-item><term id="G13">ERK</term><def><p textid="59">extracellular signal-regulated kinase</p></def></def-item><def-item><term id="G14">MEK</term><def><p textid="60">MAPK/ERK kinase</p></def></def-item><def-item><term id="G15">TS</term><def><p textid="61">TOR SMG-1.</p></def></def-item></def-list>
The abbreviations used are: HIF-1hypoxia-inducible factor-1HREhypoxia-responsive elementsiRNAsmall interfering RNAPIKKphosphoinositide 3-kinase-related kinaseWTwild typeKDkinase-deadCA9carbonic anhydrase IXMTTmethylthiazolyldiphenyltetrazolium bromideVEGFvascular epidermal growth factormTORmammalian target of rapamycinMAPKmitogen-activated protein kinaseHAhemagglutininERKextracellular signal-regulated kinaseMEKMAPK/ERK kinaseTSTOR SMG-1.
###end p 46
###begin p 47
hypoxia-inducible factor-1
###end p 47
###begin p 48
hypoxia-responsive element
###end p 48
###begin p 49
small interfering RNA
###end p 49
###begin p 50
phosphoinositide 3-kinase-related kinase
###end p 50
###begin p 51
wild type
###end p 51
###begin p 52
kinase-dead
###end p 52
###begin p 53
carbonic anhydrase IX
###end p 53
###begin p 54
methylthiazolyldiphenyltetrazolium bromide
###end p 54
###begin p 55
vascular epidermal growth factor
###end p 55
###begin p 56
mammalian target of rapamycin
###end p 56
###begin p 57
mitogen-activated protein kinase
###end p 57
###begin p 58
hemagglutinin
###end p 58
###begin p 59
extracellular signal-regulated kinase
###end p 59
###begin p 60
MAPK/ERK kinase
###end p 60
###begin p 61
TOR SMG-1.
###end p 61
###begin title 62
REFERENCES
###end title 62

